Chemoinformaics analysis of 3-Aminocyclopentanone
| Molecular Weight | 99.133 | nRot | 0 |
| Heavy Atom Molecular Weight | 90.061 | nRig | 6 |
| Exact Molecular Weight | 99.0684 | nRing | 1 |
| Solubility: LogS | 0.09 | nHRing | 0 |
| Solubility: LogP | -1.218 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 16.2531 |
| nHD | 1 | BPOL | 9.32686 |
| QED | 0.467 |
| Synth | 3.239 |
| Natural Product Likeliness | 1.524 |
| NR-PPAR-gamma | 0.019 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.029 |
| Pgp-sub | 0.104 |
| HIA | 0.018 |
| CACO-2 | -5.009 |
| MDCK | 0.0000521 |
| BBB | 0.171 |
| PPB | 0.203716 |
| VDSS | 0.799 |
| FU | 0.915659 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.1 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.141 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.116 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.821 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.206 |
| CL | 8.207 |
| T12 | 0.756 |
| hERG | 0.023 |
| Ames | 0.87 |
| ROA | 0.147 |
| SkinSen | 0.233 |
| Carcinogencity | 0.275 |
| EI | 0.21 |
| Respiratory | 0.281 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.940761 |